Medline Inc.

US$39.64As of Sun 8 Nov 2026, 12:00 UTC

NASDAQ:MDLNHealthcare

Country USA

PE (Fwd) •••

TSR 10Y CAGR —

Div yield —

ROE 4.85%

Medical Instruments & Supplies

Beta (5Y) —

PE TTM 60.81

TSR TTM —

Mkt cap US$52.14B

ROIC 4.55%

SE Grade™

Value

Quality

Moat

Consensus

Reference

$45

12.59%

299.66%

Hold 6|11|5|2|9

TTM

FYE 31 Dec USD

FY2016

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026E

Trend

10Y

Peers

5.069

Revenue$B

7.926

8.484

8.912

9.451

9.840

10.33

10.91

11.66

12.45

13.24

5.377

6.12%

5.97%

15.82

Revenue growth%

15.03

17.99

17.72

16.81

15.21

13.27

15.44

14.14

16.24

17.62

8.84

15.44

15.84

26.94

Gross margin%

35.19

35.33

33.20

32.32

34.12

31.79

29.05

29.86

31.36

29.92

7.96

29.92

32.06

5.99

Operating margin%

0.54

0.40

1.02

1.74

17.42

0.40

8.40

Net margin%

10.84

9.90

8.29

6.11

7.80

8.27

6.99

5.25

8.17

9.19

10.88

8.17

8.22

27.78

P/E ratio (avg)x

10.31

9.532

8.571

7.935

8.539

8.107

8.395

8.828

8.225

8.991

14.16

8.395

8.555

19.36

EV/EBITx

12.50

11.90

12.12

11.81

12.54

12.29

11.45

11.80

12.98

13.73

22.61

12.29

12.21

13.07

FCF yield (avg)%

2.83

1.94

2.51

3.74

4.93

4.69

3.12

0.91

2.97

0.40

28.77

2.97

2.90

8.53

FCF margin%

21.81

20.09

17.84

16.51

15.04

13.64

15.03

16.23

15.39

17.01

21.85

15.39

16.37

1.639

FCF / Net incomex

0.769

0.792

0.947

1.109

1.105

1.276

1.424

1.688

1.924

2.243

0.903

1.688

1.192

11.09

ROIC%

33.16

33.42

34.55

34.48

35.68

33.85

31.13

33.31

36.25

35.71

7.62

33.85

34.17

11.63

Return on equity%

0.40

2.90

5.07

2.17

1.13

0.45

0.40

14.31

0.40

0.43

26.84

Return on assets%

15.77

12.88

11.36

10.14

9.93

7.54

10.32

8.37

8.45

7.13

14.83

8.37

10.04

4.56

EPS$

3.72

3.93

4.04

4.75

4.64

4.50

4.70

4.76

5.64

5.72

5.00

4.26%

4.80%

—

21.46

EPS growth%

10.27

12.16

12.78

14.02

15.21

16.47

16.06

16.16

16.56

18.03

17.18

16.47

15.64

4.00

Bookvalue per sh$

0.92

0.90

0.87

0.78

0.83

0.89

0.80

0.87

0.79

0.69

2.31

(3.54%)

(2.05%)

—

2.58

FCF per share$

4.31

4.32

4.25

4.18

4.20

4.66

4.21

4.54

4.01

3.96

1.13

(1.15%)

(0.33%)

—

4.41

Dividend per sh$

2.27

1.95

1.99

2.00

1.92

1.63

1.47

1.36

1.38

1.21

2.67

(8.74%)

(5.44%)

—

18.30

Div yield (avg)%

0.40

2.72

4.05

3.98

4.95

5.82

3.19

6.11

5.22

6.40

11.46

5.82

4.50

19.90

Payout ratio%

8.24

9.16

8.16

5.64

4.63

3.27

0.58

0.40

0.97

0.54

11.46

0.58

3.95

1.278

Shares (diluted)B

2.086

2.480

2.569

2.691

2.769

2.895

3.446

3.991

4.436

4.421

1.335

9.81%

8.92%

15.67

Buyback yield%

0.40

2.31

4.34

5.28

3.52

2.81

1.12

0.40

26.53

2.81

1.72

0.329

D/E ratiox

1.487

1.611

1.692

1.639

1.857

2.172

2.376

2.305

2.596

2.867

1.093

2.376

2.014

5.787

Enterprise value$B

4.965

4.728

4.416

4.769

4.104

4.263

4.499

3.899

3.983

3.734

6.831

(1.87%)

(3.76%)

11.19

LT debt$B

9.216

9.543

10.70

11.02

11.97

11.81

12.60

12.94

12.55

12.36

2.224

0.64%

4.36%

Peers (US$52.14B)

Cap (US$)

Becton, Dickinson and…

57.71B

51.78x

ResMed Inc.

33.10B

21.43x

West Pharmaceutical…

27.85B

44.91x

HOYA Corporation

47.28B

26.66x

Capital

TTM

10Y

Leveragex

0.521

0.164

0.192

EBIT/Intx

1.643

0.504

0.368

Own earn%

29.18

62.69

76.12

Sh yield%

33.97

6.80

6.53

Owners

Insiders/Inst%

10.50

59.96

Short interest%

4.52

SBC / revenue%

2.64

Record

10Y

Profitable years

10/10

Revenue growth years

10/10

EPS growth years

10/10

Dividend streakyrs

Op margin range%

0–2

$1 testx

0.0

Incr. ROIC%

Medline Inc. manufactures med-surg products for hospitals, surgery centers, physician offices, post-acute facilities and nursing homes in the United States and internationally. Its Medline Brand segment offers surgical solutions, front line care, and laboratory and diagnostics products, while its Supply Chain Solutions segment distributes third-party products and provides logistics and supply chain optimization services.

Growth vs revenue

Latest

Trend

10Y CAGR

Rel growth

Revenue

$13.24B

5.97%

1.00×

Cost of revenue

$6.081B

6.36%

1.04×

Operating expenses

$2.875B

5.48%

0.95×